Podcasts about pharmaceuticals

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today I'm excited to have board-certified internist and complex chronic disease expert, Dr. Tania Dempsey back on the podcast to discuss parasites. Hidden parasites are more common than you think and may even be related to conditions such as SIBO, IBS, Histamine intolerance and poor immune system health. We'll cover the types of parasites, best testing options, a treatment protocol and how to prevent parasites. You don't want to miss this!  Start healing with us! Learn more about our virtual clinic:  https://drruscio.com/virtual-clinic/   Follow Dr. Tania Dempsey https://drtaniadempsey.com/about/ https://drtaniadempsey.com/podcast/ https://www.instagram.com/drtaniadempseymd/ https://www.youtube.com/@DrTaniaDempsey https://www.facebook.com/taniadempseymd/  

In this episode of 'Resilience Unravelled,' Dr. Joe Nieusma, a toxicologist with 37 years of experience, discusses the effects of toxins on the human body. Dr. Joe explains the basics of toxicology, emphasising the principle that 'the dose makes the poison.' He elaborates on how both external and internal toxins affect health, highlighting issues like oxidative stress and chronic inflammation. Dr. Joe also shares practical advice on maintaining cellular health through proper diet, hydration, exercise, and sleep. Additionally, he introduces Carbon 60 as a powerful antioxidant and discusses his work in addressing post-fire toxic exposures in Southern California.00:00 Introduction 00:56 Understanding Toxicology05:26 External Toxins: Voluntary and Involuntary Risks08:08 Internal Toxins and Autoimmunity12:56 Improving Cellular Health14:39 The Role of Antioxidants and Carbon 6019:44 Oxidative Stress and Aging20:20 Product Formulations and Benefits21:15 Personal Experiences and Testimonials26:33 Inflammation and Its Impacts29:38 Pharmaceuticals vs. Natural Alternatives32:02 Practical Health Tips35:20 Product Recommendations and Contact Information37:17 Concluding RemarksYou can contact us at info@qedod.comResources can be found online or link to our website https://resilienceunravelled.com#resilience, #burnout, #intuition

Our guest on this week's episode is Joel Wayment, VP/GM at Cardinal Health Third Party Logistics and Packaging Solutions. We are definitely in the dog days of summer and in just about every part of the country we are really feeling the heat. While many people like to soak up the sun's rays, high temperatures are not so welcome for the pharmaceuticals we rely on to stay healthy every day. A lot of drugs have to be kept at strict temperatures to remain effective. But how challenging is it to assure proper conditions as drugs move through our supply chains? Our guest offers his expertise on how to assure the safety of important drugs while transiting summer heat.Incidents of cargo theft are on the rise. One of the most recent pieces of evidence is a report from supply chain visibility and risk analysis firm Overhaul. The company's United States Q2-2025 Cargo Theft Report found that cargo theft rose 33% year-over-year in the second quarter of 2025. That continues a steady climb in such incidents over the past few years. And they expect thefts to increase in the coming months of peak season.According to the management consulting firm Kearney, the global food system is breaking away from traditional operating models as companies are struggling to protect their operating margins. Rising costs of food production are having major impacts on the food supply chain. We discuss the problems and possible solutions.Supply Chain Xchange  also offers a podcast series called Supply Chain in the Fast Lane.  It is co-produced with the Council of Supply Chain Management Professionals. A new series is now available on Top Threats to our Supply Chains. It covers topics including Geopolitical Risks, Economic Instability, Cybersecurity Risks, Threats to energy and electric grids; Supplier Risks, and Transportation Disruptions  Go to your favorite podcast platform to subscribe and to listen to past and future episodes. The podcast is also available at www.thescxchange.com.Articles and resources mentioned in this episode:Cardinal HealthReport: Q2 cargo theft up 33% year-over-yearKearney: Global food system in midst of an overhaulLogistics industry growth slowed in JulyVisit Supply Chain XchangeListen to CSCMP and Supply Chain Xchange's Supply Chain in the Fast Lane podcastSend feedback about this podcast to podcast@agilebme.comPodcast is sponsored by: Storage SolutionsOther linksAbout DC VELOCITYSubscribe to DC VELOCITYSign up for our FREE newslettersAdvertise with DC VELOCITYJoin the Logistics Matters team at CSCMP EDGE 2025, October 5-8 at the Gaylord in Washington, D.C. Go to CSCMP.org to find out more.

Pharmaceutical companies are scrambling to respond to the Trump administration's tariff threats, seeking to mitigate duties on their products while keeping the impact on their tax bills to a minimum.   The industry has long leveraged complex transfer pricing arrangements to cut down on its tax bills, but now the looming tariffs could spark a major rethink for where companies make their drugs and the location of their crown jewel: the intellectual property. Pharmaceuticals were exempt from the initial wave of tariffs announced earlier this year, but subsequent months have seen threats of heavy fines and taxes from the administration and a looming national security investigation, which could result in heavy duties on the industry.   In this week's Talking Tax podcast, Cronus Consulting founder Nick Shipley talked with reporter Caleb Harshberger about how pharmaceutical companies are navigating the chaos, and what it could mean for their tax planning and operations. Shipley is a consultant for the pharmaceutical industry. Do you have feedback on this episode of Talking Tax? Give us a call and leave a voicemail at 703-341-3690.

Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be discontinued.

"Burnout and trauma are not mental illnesses. They live in your physiology. They live in your biology. They live very specifically in your nervous system,” Dr. Rola Hallam says with a conviction rooted in her own successful journey to overcome the effects of chronic stress she accumulated during many years on the frontlines of humanitarian crises in Syria and other conflict zones. Out of concern for the multitudes of health professionals who, like herself, spend years carrying the weight of their traumatic experiences without seeking help, or who pursue ineffective remedies for relieving it, Dr. Rola -- as she's known – has shifted her focus to being a trauma and burnout coach. Among her offerings is Beyond Burnout, a twelve-week program that includes multimedia content as well as live coaching and teaching about developing nervous system awareness and regulation. “Most wellness initiatives fail because they're not rewiring the nervous system to come out of survival mode and back into what is called the ventral-vagal state, which is our state of social connection and of healing and repair.” She also stresses that healing is not an individual pursuit, especially for providers who work in a relational field, and teaches about the benefits of borrowing from a colleagues' state of calm and offering them the same. Don't miss this insightful and giving conversation with host Lindsey Smith that covers Dr. Rola's wrenching experiences providing care in desperate conditions, the critically important distinction between empathy and compassion, and how empowering frontline workers to heal their trauma can uplift individuals and empower entire communities. Mentioned in this episode:Dr. Rola CoachingBeyond Burnout AssessmentCanDo - Humanitarian Aid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“Seeing that you can get through the most difficult times in life, succeed, and then also return to your community and work in service to your community was a lesson that has stuck with me,” says Dr. Uche Blackstock, the Founder and CEO of Advancing Health Equity and our guest on this inspiring episode of Raise the Line with Osmosis from Elsevier. It was a lesson the Harvard-trained physician learned from her own mother – also a Harvard trained physician – who overcame poverty, sexism and racial bias to forge an inspiring path.  In her bestselling book, Legacy: A Black Physician Reckons with Racism in Medicine, Dr. Blackstock weaves her mother's remarkable story with her own and argues for systemic change in a healthcare system riddled with racially-biased practices and policies that impact patient outcomes. As she explains to host Lindsey Smith, Advancing Health Equity's work to drive measurable and sustainable change is focused on embedding equity as a core value in the leadership, strategy, and organizational practice of health systems. “We exist to challenge inequities, empower underrepresented communities, and help build a healthcare system where everyone can thrive.” Don't miss a thought-provoking conversation with a nationally respected voice that also addresses race correction factors that impact the care of Black patients, and the work required of health institutions to build trust in effected communities.Mentioned in this episode:Advancing Health EquityLegacy: A Black Physician Reckons with Racism in Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare brain tumor.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Novo Nordisk's new CEO, Maziar Mike Doustdar, is focusing on developing more drugs for obesity and diabetes while trimming the company's pipeline. The Department of Health and Human Services is terminating around $500 million in contracts for mRNA vaccine development, affecting companies like Moderna and Pfizer. Chinese biotechs are turning to big pharma for partnerships to survive, while Trilink Biotechnologies offers process development services for nucleic acid therapeutic development. Other top stories include biopharma CEOs being pulled into policy discussions, Bayer expecting more layoffs, and Trump threatening high tariffs on pharmaceuticals. The industry is also seeing investments in future technologies and strategies, such as AI for real-world research and integrated supply chain strategies for pharma manufacturing.Big pharma is providing support to struggling Chinese biotech companies by out-licensing drugs to multinational corporations. The recent increase in deals highlights the potential for partnerships with biotechs in the region. Biopharma CEOs are facing policy questions from tariffs to drug pricing, impacting their second quarter earnings calls. AI can help pharmaceutical companies adapt to policy pressures in the regulatory environment. Big pharmas are investing in incubators and venture funds to uncover scientific trends and determine future focus points. Pfizer's CEO is in contact with the President over drug pricing policies, while Moderna is focused on R&D partnerships rather than mergers and acquisitions. Novo's new CEO is emphasizing execution in obesity and diabetes research while trimming their pipeline. Biontech is committing to infectious diseases amid concerns over vaccine demand. Trump's threat of high pharma tariffs, a surge in July layoffs, and legal battles between Moderna, Pfizer, and Biontech are also making headlines. Events on AI for real-world research and integrated supply chain strategies for pharma manufacturing are upcoming, along with job opportunities in biostatistics, manufacturing, and publications.

Welcome to the 9News podcast. A snapshot of the latest stories from the9News team including Tariff threat looms over pharmaceuticals, Aussie tourist reflects on deadly boat crash and athletes honoured. The biggest news stories in less than 10 minutes delivered three times a day,with reports from the 9News team across Australia and overseas. Subscribenow to make it part of your daily news diet.See omnystudio.com/listener for privacy information.

Season 10 is heating up! After a workroom Hoe Down with Andy Cohen and some questionable wig choices, Ru challenges the queens to a Rusical Challenge about the booming Pharmaceuticals industry. The queens serve “Best Drag” on the runway, which is a debatable term at this point. And Willam continues to want to talk about Blair St. Clair! Listen to Race Chaser Ad-Free on MOM Plus Follow us on IG at @racechaserpod and click the link in bio for a list of organizations you can donate to in support of Black Lives Matter FOLLOW ALASKA https://twitter.com/Alaska5000 https://www.instagram.com/theonlyalaska5000 https://www.facebook.com/AlaskaThunder https://www.youtube.com/channel/UC9vnKqhNky1BcWqXbDs0NAQ FOLLOW WILLAM https://twitter.com/willam https://www.instagram.com/willam https://www.facebook.com/willam https://www.youtube.com/channel/UCrO9hj5VqGJufBlVJy-8D1g RACE CHASER IS A FOREVER DOG PODCAST Learn more about your ad choices. Visit megaphone.fm/adchoices

US tariffs of up to 250 percent - that's what pharmaceutical imports could soon be facing But what would this mean for the makers and distributors of non-branded medicines? We'll be speaking to an association representing them.Is Europe turning its back on Tesla? Electric car sales from the company continue to drop in Europe, but sales from Chinese electric carmaker BYD are on the rise. An automotive analyst tells us why.And WhatsApp says it has shut down almost seven million accounts linked to scammers in the first half of the year. WhatsApp's external affairs director explains more.

The Smart 7 is an award winning daily podcast, in association with METRO, that gives you everything you need to know in 7 minutes, at 7am, 7 days a week…With over 18 million downloads and consistently charting, including as No. 1 News Podcast on Spotify, we're a trusted source for people every day and we've won Gold at the Signal International Podcast awardsIf you're enjoying it, please follow, share, or even post a review, it all helps... Today's episode includes the following:https://x.com/i/status/1952681227913138532https://x.com/i/status/1952700209407852935https://x.com/i/status/1952637430886011347https://x.com/i/status/1952641094279115024 https://x.com/i/status/1952706835523178827 https://x.com/i/status/1952726096941580412 https://x.com/i/status/1952782961478086967 https://youtu.be/4dHJHh6GpqE https://youtu.be/hJYPGhJDjaUContact us over @TheSmart7pod or visit www.thesmart7.com or find out more at www.metro.co.uk Voiced by Jamie East, using AI, written by Liam Thompson, researched by Lucie Lewis and produced by Daft Doris. Hosted on Acast. See acast.com/privacy for more information.

European Pharmaceutical stocks have dropped over the past day, following a fresh threat from US President Donald Trump to impose tariffs of up to 250%. For more on this Jennifer Ewing is a spokesperson for Republicans Overseas UK and Olof Gill, Spokesperson for the European Commission.

Yesterday, US President Donald Trump announced that upcoming tariffs on imported pharmaceuticals could reach 250%, after starting at a lower level. Trump also added he plans to unveil fresh duties on foreign semiconductors. Speaking to Pat this morning was Shona Murray, Europe Correspondent for Euronews and also Gareth Sheridan, CEO of Nutriband.

A mysterious dust fills a young family's apartment. The truth begins to unravel when the mother gets a call from the pediatrician - the monster deep within the walls has been unleashed. LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett. EP1 features Zak Orth, Jenny Maguire, Daphne Gaines, and Micheal Gaston. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

President Trump signals pharmaceuticals could be next on his tariffs list. But what does that mean for the makers and distributors of non-branded medicines? We'll be speaking to an association representing them. Love it or loathe it, AI is creeping into everyday life. But how much of a threat does AI pose to emerging economies? The president of the World Bank Group shares his thoughts. And in electric car sales in Europe it's bad news for Tesla, but much brighter news for BYD. We'll look at the reasons for the difference in performance for the rival carmakers.

The Earth is spinning faster, Everything about Russia Russia Russia was a lie, Did Micah Step in it again? Round 2, Trump will not replace Powell with Bessent, Tariffs on Pharmaceuticals, Banks that refuse to work with conservatives should be hit with penaltiesSee omnystudio.com/listener for privacy information.

Pam Bondi has directed her staff to act on the criminal referrals submitted by Tulsi. Israel makes it official: They are taking Gaza, Gov. Abbott orders arrest of Texas Democrats. American Eagle stock is up. No visas for transgender athletes. There are theories about that NYC shooting. Did Micah Beckwith step in it again? Sen. Elizabeth Warren endorses Zohran Mamdani for NYC mayor. Jukebox Hero. ICE agents detain Purdue student. The Earth is spinning faster, for at least one day. Everything about Russia Russia Russia was a lie, Did Micah Step in it again? Round 2. Trump will not replace Powell with Bessent, Tariffs on Pharmaceuticals. Banks that refuse to work with conservatives should be hit with penaltiesSee omnystudio.com/listener for privacy information.

US President Donald Trump has said that upcoming tariffs on imported pharmaceuticals could reach 250%, after starting at a lower level, while adding he plans to also unveil fresh duties on foreign semiconductors.To discuss, Kieran is joined by Economist and Co-Host of 'The Other Hand' podcast, Jim Power.

Patients with behavioral health and substance use disorders often struggle with accessing and staying on the daily oral medications they need to keep their disorders controlled. That's why SSM Health uses some of its 340B savings to run long-acting injectable (LAI) clinics in the St. Louis area to help these patients achieve better health. We speak with SSM Health Vice President of Pharmacy Financial Operations Michelle Schmitt to learn how much of a role 340B plays in that patient care mission.LAI clinics offer comprehensive servicesSSM Health's three LAI clinics offer injections for patients with conditions such as bipolar disorder, schizophrenia, and alcohol and opioid use disorders that might last as long as three to six months. Clinic visits also give the patients access to a full team of pharmacists, psychiatrists, nurses, therapists, and others to help them navigate treatment and stay healthy.340B funds are key to patient accessBecause behavioral health is often a subsidized service, 340B savings are crucial to the operations of the clinics. They also enable SSM Health to offer financial assistance to patients living up to 400% of the poverty level so they can afford the treatments they need to stay on the road to recovery.Cuts to 340B would be detrimental to patientsSchmitt says losing access to 340B pricing could mean a 60-70% price increase in the cost of LAI drugs, which would threaten the viability of the clinics and the financial assistance that many patients rely on to access their treatments. She says these clinics are a great example of how 340B is about much more than just price discounts; it provides resources for health systems to meet unique community health needs and serve patients where they are.ResourcesFederal Legislation Would Ban Harmful Drug Company Restrictions on 340B

The Rite Aid closures have created a gap for many who are seeking a new pharmacy. and Don Arthur, owner of Brighton Eggert Pharmacy, shares what you should know about switching over.

“Pandemics are a political choice. We will not be able to prevent every disease outbreak or epidemic but we can prevent an epidemic from becoming a pandemic,” says Dr. Joanne Liu, the former International President of Médecins Sans Frontières/Doctors Without Borders and a professor in the School of Population and Global Health at McGill University. You are in for a lot of that sort of frank and clear-eyed analysis in this episode of Raise the Line from Dr. Liu, whose perspective is rooted in decades of experience providing medical care on the frontlines of major humanitarian and health crises across the globe, as well as wrangling with world leaders to produce more effective responses to those crises and to stop attacks on medical facilities and aid workers in conflict zones. Firsthand accounts from the bedside to the halls of power are captured in her new book Ebola, Bombs and Migrants, which focuses on the most significant issues during her tenure leading MSF from 2013-2019.  The book also contains insights about the geopolitical realities that hamper this work, including lax enforcement of international humanitarian law, and a focus on national security that erodes global solidarity. Join host Lindsey Smith as she interviews this leading voice on our preparedness to meet the needs of those impacted by violent conflict, forced migration, natural disasters, disease outbreaks and other grave challenges. If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Too much estrogen — even the fake kind — is wrecking our health. In this episode, Kathy and I break down the hidden endocrine disruptors lurking in your bathroom: shampoos, lotions, deodorants, candles, and even “natural” products that aren't so natural. We share the exact non-toxic swaps we've made over the years (without breaking the bank), and why some “clean” labels still aren't enough. We also dive into feminine health, EMF mitigation, and the real reason birth control might be one of the most damaging drugs women are prescribed — and what to do instead. This is Part 2 of our series on everyday toxins and how to avoid them — simple shifts that protect your hormones, fertility, skin, and long-term health. Learn more: Download for FREE the Ultimate Non-Toxic Essentials Guide: https://michaelkummer.com/non-toxic-products/ Get 10% off Waveblock with the code KUMMER10 at: https://michaelkummer.com/go/waveblock Young Goose: Get 5% off with my discount code MKUMMER: https://michaelkummer.com/go/younggoose Mother Fo Care: Get 15% off with my discount code Winter15 https://motherfocare.com/  Thank you to this episode's sponsor, OneSkin! OneSkin's lineup of topical skin health products leverage the power of the company's proprietary OS-01 peptide to remove dead skin cells, improve collagen production, increase skin hydration and more.  Check out my before and after photos in my OneSkin review: https://michaelkummer.com/health/oneskin-review/  Get 15% off with my discount code MKUMMER: https://michaelkummer.com/go/oneskinshop  In this episode: 00:00 Intro 01:40 Personal care products and fragrances 03:25 Swapping to non-toxic alternatives 04:54 Deodorants and skincare 09:19 Pharmaceuticals and hormones 12:13 Feminine health and birth control 15:32 EMF mitigation strategies 19:41 Conclusion and final tips Find me on social media for more health and wellness content: Website: https://michaelkummer.com/ YouTube: https://www.youtube.com/@MichaelKummer Instagram: https://www.instagram.com/primalshiftpodcast/ Pinterest: https://www.pinterest.com/michaelkummer/ Twitter/X: https://twitter.com/mkummer82 Facebook: https://www.facebook.com/realmichaelkummer/ [Medical Disclaimer] The information shared on this video is for educational purposes only, is not a substitute for the advice of medical doctors or registered dietitians (which I am not) and should not be used to prevent, diagnose, or treat any condition. Consult with a physician before starting a fitness regimen, adding supplements to your diet, or making other changes that may affect your medications, treatment plan, or overall health. [Affiliate Disclaimer] I earn affiliate commissions from some of the brands and products I review on this channel. While that doesn't change my editorial integrity, it helps make this channel happen. If you'd like to support me, please use my affiliate links or discount code. #NonToxicProducts #WellnessOptimization   

In this conversation, Dr. Elizabeth Klodas, a preventive cardiologist and founder of Step One Foods, discusses the critical role of nutrition in managing heart disease and the challenges faced in integrating dietary changes into medical practice. She shares her journey from traditional medicine to creating a food company aimed at reducing reliance on medications through nutrition. The discussion highlights the importance of randomized controlled trials in validating the effectiveness of food-based interventions, the impact of pharmaceuticals on healthcare, and the need for a shift in consumer perceptions towards whole food ingredients. Dr. Klodas emphasizes the potential for a healthier future where cardiologists are less needed due to preventive measures and lifestyle changes.Takeaways:Nutrition is often overlooked in favor of pharmaceuticals in healthcare.Patients are rarely asked about their diet by healthcare providers.Changing dietary habits can lead to significant health improvements.Pharmaceuticals are easier to prescribe than dietary changes.There is a lack of nutrition education in medical training.Step One Foods aims to fill nutritional gaps in patients' diets.Randomized controlled trials can validate the effectiveness of food products.Consumer perceptions of health foods can be influenced by marketing.The food industry often prioritizes cost over nutrition.A better world would mean fewer cardiologists needed due to preventive health measures.Sound bites:“There is very little to no nutrition education for physicians. As I look back on this I consider this educational malpractice.”“All the medical evidence of what we should be doing is very heavily pharma biased, because guidelines are based on randomized control clinical trials.”“So there's loads of reasons why nutrition is not used in clinical care the way it should be. None of that is an excuse though, because it works and it's so vital.”“What if I asked you to like eat this food twice a day and I otherwise left you alone? What started happening is people calling and saying, hey, my cholesterol dropped 39 points. Then I'm like, okay, we're gonna subject our products to a randomized control trial. Let's see. Let's prove it. Does this actually work?”“If I reduce, LDL, the bad cholesterol across the US population by an average of 9%, I will finally dethrone heart disease as our number one killer.”“In that trial, we replicated what people were calling in with our highest LDL reduction was close to 40 % in 30 days. That's a medication level cholesterol reduction. And we did that with food, without turning people's lives upside down.”“It's not just the nutrient of interest that's important. It's the delivery vehicle. You can stuff a bunch of fiber into a Twinkie. But in the end, you're still eating a Twinkie, right? Food and nutrition is complex.”“At Step One Foods I take the complexity out for people. I take whole food ingredients, each and every single one that has data behind it in terms health benefits, and put them in my foods.”“We are probably the most overfed and undernourished society in the history of our species.”“If you truly believe in your mission, you have to ignore all the no's.”Promo Offer:Code: BETTERWORLDLink: https://www.steponefoods.com/discount/BETTERWORLDOffer: 10% off first order for both one time and subscription orders. Offer can be stacked with the subscription discount to save 30% on their first order. Exclusions: Limited to one use per customer. Limited to a customer's first order and only applies to the first recurring order. Code must be entered at checkout for the discount to be applied. Links:Dr Elizabeth Klodas on LinkedIn - https://www.linkedin.com/in/eklodas/Step One Foods- https://www.steponefoods.com/Step One Foods on LinkedIn - https://www.linkedin.com/company/steponefoods/Step One Foods on Facebook - https://www.facebook.com/StepOneFoodsStep One Foods on Instagram - https://www.instagram.com/steponefoods/Step One Foods on YouTube - https://www.youtube.com/StepOneFoods…“Slay the Giant: The Power of Prevention in Defeating Heart Disease” book - https://www.steponefoods.com/products/slay-the-giant…Brands for a Better World Episode Archive - http://brandsforabetterworld.com/Brands for a Better World on LinkedIn - https://www.linkedin.com/company/brand-for-a-better-world/Modern Species - https://modernspecies.com/Modern Species on LinkedIn - https://www.linkedin.com/company/modern-species/Gage Mitchell on LinkedIn - https://www.linkedin.com/in/gagemitchell/…Print Magazine Design Podcasts - https://www.printmag.com/categories/printcast/…Heritage Radio Network - https://heritageradionetwork.org/Heritage Radio Network on LinkedIn - https://www.linkedin.com/company/heritage-radio-network/posts/Heritage Radio Network on Facebook - https://www.facebook.com/HeritageRadioNetworkHeritage Radio Network on X - https://x.com/Heritage_RadioHeritage Radio Network on Instagram - https://www.instagram.com/heritage_radio/Heritage Radio Network on Youtube - https://www.youtube.com/@heritage_radioChapters:03:00 Introduction to Preventive Cardiology and Nutrition05:58 The Shift from Nutrition to Medication in Healthcare08:45 The Role of Pharmaceuticals in Patient Care11:41 The Challenges of Nutrition Education in Medicine14:41 The Complexity of Food and Nutrition Science17:59 Step One Foods: A New Approach to Nutrition20:57 The Impact of Randomized Controlled Trials on Nutrition23:59 The Importance of Ingredient Quality in Food Products26:49 Pushback from the Medical and Food Industries29:52 The Insurance Industry's Role in Healthcare Costs32:52 Step One Foods: Product Overview and Benefits38:43 Introduction to Whole Foods and Health Claims40:56 The Importance of Real Ingredients42:56 Navigating Organic Ingredients and Supply Chain Challenges44:59 Stepwise Approach to Health and Nutrition48:58 Challenges in Scaling Food Production51:49 Milestones and Industry Changes56:55 Advice for Aspiring Food Entrepreneurs59:50 Personal Indulgences and Food Preferences01:03:00 Innovative Thinkers in Nutrition01:05:50 Vision for a Healthier WorldSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textIt seems as though the great ‘Paleo Boom' has come and gone!  All the books, all the podcasts- where have they gone?I've been writing and podcasting for more than 10 years; I used to listen to Robb Wolf and The Paleo Solution, Jimmy Moore and Livin La Vida Low Carb, Mark Sisson and his Primal Podcast, and many others.  Don't hear much from Robb Wolf anymore- Jimmy Moore is locked in prison for God's sake- and Primal goes on, and is just kind of Paleo with a different name…Now, the cutting edge seems to be focussed on Carnivore, with Sean Baker and others.  But is this carnivore pivot really all that much different than Paleo or Primal?Not really.  Those are all just words that encapsulate a certain set of ideas- that living in a more ancestral way, more in keeping with that of our forebears, is far healthier and more beneficial than the modern, pharmaceutical and processed foods-based version of the present day.  In other words, simpler is better.Carnivore could easily be another word for Paleo.  It's just another, more extreme way to practice the way our ancestors lived.  It is certainly A way, and a very simple way to have a ‘restart' with your health, that is possibly really messed up in the present day.I mean, you could call your paleo type of diet ‘The Great Grandparents diet', or the ‘Post nuclear apocalypse Diet', and the results would be very similar.  The idea is just to get away from the modern conventions and pronouncements of current ‘experts' and getting back to timeless sorts of recommendations from the past.  Time-tested and proven methods of health and wellness that have stood the test of time- of millennia- and not just those ideas that are being pushed by Big Medicine and the modern trinity of Pharmaceuticals, Big Food, and the Government .You know: Moe, Larry and Curly. The EXPERTS!I'm being a bit facetious, but in light of Fauci and the Covid disaster, along with the Low Fat food recommendations of the past 60 to 70 years, and the endless recommendations of Vegetable Seed Oils in our diets, well, the “experts” aren't looking too expert really, are they?And let's not forget the Exercise recommendations- “run long distances to gain complete fitness and above all, heart health…”.  More nonsense in place of simple strength training, walking, and stretching!  Grounding barefoot by walking on the earth, rather than sprint-running to exhaustion in timed races on tracks with over-cushioned shoes.I'm sure you get the idea.  The Paleo Diet and Lifestyle hasn't gone away, not at all.  Maybe the erstwhile leaders have left the field, moving on to other endeavors.  But the movement is intact, as strong as it was when it was being promoted by figures such as Weston A. Price, the dentist who noticed in the 1920's and 30's the wonderful health of pre-industrial people who ate their ancestral diets and moved in the manner in which they had evolved over long periods of time.  All of the tenets of Paleo are intact, and correct.  Eliminate most of ‘modern medicine', including most vaccines and pharmaceutical drugs, especially for our children.  Go back to ancient leaders, like Hippocrates, who said in old Greek times to “Let thy medicine be thy food, and thy food be thy medicine”.  This is timeless truth!Eat good, basic foods like meat and dairy.  Fermented dairy is best, and raw dairy is better than processed!  Likewise with grains- they are optional, but if made in accordance with established traditions, such as sourdough fermentation, they can Support the show

Lexi Silver is 15 years old. She lost both of her parents before she turned 11. That should tell you enough—but it doesn't. Because Lexi isn't here for your pity. She's not a sob story. She's not a trauma statistic. She's a writer, an advocate, and one of the most emotionally intelligent people you'll ever hear speak into a microphone.In this episode, Lexi breaks down what grief actually feels like when you're a kid and the adults around you just don't get it. She talks about losing her mom on Christmas morning, her dad nine months later, how the system let her down, and how Instagram trolls tell her she's faking it for attention. She also explains why she writes, what Experience Camps gave her, how she channels anger into poems, and what to say—and not say—to someone grieving.Her life isn't a Netflix drama. But it should be.And by the way, she's not “so strong.” She's just human. You'll never forget this conversation.RELATED LINKS• Lexi on Instagram: @meet.my.grief• Buy her book: The Girl Behind Grief's Shadow• Experience CampsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The EU and the US agreed that US consumers should pay more tax—levied at 15% for imports from the EU. EU President von der Leyen made vague pledges to buy stuff from and invest in the US, without the necessary authority to make those pledges reality. Pharmaceuticals and steel seem to be excluded from this deal. The result is better for the US economy than the worst-case scenario, but worse for the US economy than the situation in January this year—but it is bad news markets have probably anticipated.

In this conversation, Leigh Brandon and Leeza discuss Leeza's journey into holistic health, her personal experiences with eczema, and the importance of diet, detoxification, and emotional well-being in skin health. They explore the role of boundaries in health, the challenges of navigating the medical system, and the significance of patience and persistence in the healing journey. Leeza shares her insights on empowering others to reclaim their health and the importance of supporting the body through natural means.Chapters00:00 Introduction to the Podcast and Transition to Video03:06 Leeza's Journey into Holistic Health05:58 The Impact of Eczema on Leeza's Life08:47 Understanding the Root Causes of Skin Conditions11:55 Detoxification and Its Effects on Skin Health14:48 The Role of Emotions in Physical Health17:32 The Importance of Taking Responsibility for Health20:46 The Limitations of Conventional Dermatology23:42 The Connection Between Diet and Skin Health26:29 Reflections on Personal Health Journeys29:23 The Dangers of Pharmaceuticals and Heavy Metals32:10 Topical Steroid Withdrawal and Its Consequences36:12 The Dangers of Corticosteroids38:24 Personal Experiences with Dermatology42:34 The Journey to Healing Psoriasis48:18 The Importance of Patience in Healing54:39 The Role of Boundaries in Health59:28 Nature's Healing Power and Personal GrowthYou can find Leeza @:https://alkaliyogi.comhttps://www.instagram.com/alkaliyogiSend us a textSupport the showDon't forget to leave a Rating for the podcast!You can find Leigh @: Leigh's website - https://www.bodychek.co.uk/ Chronic Pain Breakthrough Blueprint - https://www.bodychek.co.uk/freepainguide/ Leigh's courses: StickAbility - https://stickabilitycourse.com/ Mastering Client Transformation (professional course) - https://www.functionaldiagnosticnutrition.com/mastering-client-transformation/

In this episode of The Midweek Takeaway, Phil Carroll and Kevin Hornsby are joined by James Short, CEO of Celadon Pharmaceuticals (AIM: CEL), to discuss the company's major strategic update. Celadon has announced plans to delist from the AIM market and transition to a private limited company, subject to shareholder approval at the upcoming General Meeting on 28 July 2025. James explains the reasoning behind this bold move, its implications for investors and patients, and how the business will continue to evolve in the medical cannabis space as a privately held company. Disclaimer & Declaration of Interest This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast. 

Elevidys shipments paused following third death; FDA committee votes against brexpiprazole combo for PTSD; Rapiblyk now available for SVT; sleep apnea pill looks promising; JUUL e-cigarettes gain marketing authorization.

“As parents dedicated to getting a treatment for our children in their lifetimes, we have turned the rare disease drug development landscape upside down and created a new model,” says Nicole Johnson, co-founder and executive director of the FOXG1 Research Foundation.  That's not an exaggeration, as the foundation is on track to make history as it begins patient clinical trials on a gene replacement therapy next year. The former TV news producer and media executive unexpectedly entered the world of patient advocacy and drug research after her daughter, Josie, was born with FOXG1, a genetic disorder which causes severe seizures and impedes normal movement, speech, and sleep among other problems. Johnson is also making an impact in another important dimension of the rare disease space in her efforts to educate parents, teachers, and students about disability inclusion through her Joyfully Josie book series and “Live Joyfully” education programs. Tune-in to this fascinating Year of the Zebra conversation with host Lindsey Smith to find out how the foundation is aiming to bring a drug to market in less than half the time and at a fraction of the cost than the industry standard, and how this model might impact research on other rare disorders. Mentioned in this episode:FOXG1 Research FoundationJoyfully Josie Book If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Michelle Andrews built a career inside the pharma machine long before anyone knew what “DTC” meant. She helped launch Rituxan and watched Allegra commercials teach America how to ask for pills by name. Then she landed in the cancer fun house herself, stage 4 breast cancer, and learned exactly how hollow all the “journey” slide decks feel when you're the one circling the drain.We talk about what happens when the insider becomes the customer, why pill organizers and wheat field brochures still piss her off, and how she fired doctors who couldn't handle her will to live. You'll hear about the dawn of pharma advertising, the pre-Google advocacy hustle, and what she wants every brand team to finally admit about patient experience.If you've ever wondered who decided windsurfing was the best way to sell allergy meds—or what happens when you stop caring if you make people uncomfortable—listen up.RELATED LINKSMichelle Andrews on LinkedInTrinity Life Sciences – Strategic AdvisoryJade Magazine – Ticking Time Bombs ArticleNIHCM Foundation – Breast Cancer StoryFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tune in as Dr Daejin Adiboye, Vice President, Therapeutic Area Head, Solid Tumor Oncology, AbbVie, explores both the evolution of cancer care and his leadership style over the last two decades. Together, Daejin and Jade discuss the lessons from his time in the clinic that shaped who he is today, the move to precision medicine in oncology, his work with the Cancer Support Community in San Francisco and much more. A little more on EMJ GOLD's guest… Dr Daejin Abidoye serves as Vice President, Therapeutic Area Head for Solid Tumor Oncology at AbbVie. In this role, he is responsible for the clinical development of all assets in late oncology clinical development.  His career includes over 20 years of experience in oncology, cancer research and drug development. Prior to joining AbbVie, Daejin was the Therapeutic Area Lead for Oncology Development and Clinical Research at Gilead Sciences. He has also held various roles at Seattle Genetics and Roche-Genentech. Dr. Abidoye is a board-certified oncologist with a career in clinical practice at Scripps Health in Southern California. 

About three years after being signed into law, one provision of the Inflation Reduction Act (IRA) that is of particular importance to 340B hospitals is about to take effect: Medicare price caps. Jan. 1, 2026, marks the date that the first 10 Medicare drugs will be subject to a maximum fair price (MFP). Meetali Desai, director of pharmacy business services at UMass Memorial Medical Center, joins us to explain how this will affect 340B hospitals and health centers such as hers.The Good and Bad News for Covered EntitiesThe good news, Desai says, is that there is potential for the 340B ceiling prices to go down for certain medications. This is because the MFP will become the new “best” price in the formula for calculating 340B prices. However, because the law will cap reimbursement rates to MFP when Medicare patients receive those drugs, 340B hospitals will see their 340B savings amounts go down for those dispenses.Updated Calculator Can Help Hospitals Gauge Potential Impact340B Health recently updated its calculator for hospitals to use to estimate the effects of MFP pricing based on the newest data. This new calculator allows users to project what the potential impact from the IRA could be on a hospital, including if drugmakers decide to lower their list prices significantly to avoid IRA inflation penalties. This drop in prices of Medicare drugs could result in 340B hospitals seeing higher ceiling prices and reduced savings.Reduced Savings Could Impact Patient CareDesai says Medicare price caps, combined with other financial pressures on hospitals, could mean some rough times ahead for hospitals that care for a large proportion of low-income patients. She encourages 340B teams to share their results from the IRA calculator with their senior leadership and with 340B Health as the hospital community prepares for the impact of these caps.ResourcesUse Our IRA Calculator and Share How Your 340B Savings Will ChangeRead Our Analysis: Second Federal Court Affirms HRSA's Authority Over 340B Rebates

Dr. Sandra Silberman, Chief Medical Officer at CNS Pharmaceuticals, has developed new therapies for glioblastoma that can cross the blood-brain barrier to reach brain tumors. Their lead drug candidates have been modified to slip into the membranes to inhibit tumor growth and attack the cancer cells. The anthracycline-based and taxane-based drugs are showing efficacy in clinical trials and are not showing the cardiotoxicity associated with anthracyclines. Sandra explains, "Anthracyclines are characteristically cardiotoxic. And we have just conducted a study of over 160 patients who have received this, and some of them for quite a long period of time. And we have not seen any cardiotoxicity. So we have one of the anthracyclines that is the first to actually cross the blood-brain barrier without any help from other mechanisms, and it also doesn't cause cardiotoxicity. So we have a really open field to be able to further develop this drug. And we know that this drug, based on all of our preclinical studies, is very effective against glioma cells." "This is to the great credit of the chemists that we've been working with. Can I develop a compound that can not be a substrate for this, so it can't even bind to this efflux transporter and can slip by? But not only that, can it be lipophilic, meaning it can get through all those membranes, and it can be something that leaks into the brain itself. So the two molecules that we have are not substrates for these multidrug-resistant transporters. They're also very highly lipophilic, meaning they're very oily. And so I guess this has two meanings to it, but they're oily and then they slip into the brain and are able to do what they're supposed to be doing, which is the inhibition of tumor growth and killing the tumor cells." #CNSPharma #Glioblastoma ##BrainCancer #BloodBrainBarrier #NeuroOncology #CancerResearch #DrugDevelopment #BrainTumor cnspharma.com  Download the transcript here

Dr. Sandra Silberman, Chief Medical Officer at CNS Pharmaceuticals, has developed new therapies for glioblastoma that can cross the blood-brain barrier to reach brain tumors. Their lead drug candidates have been modified to slip into the membranes to inhibit tumor growth and attack the cancer cells. The anthracycline-based and taxane-based drugs are showing efficacy in clinical trials and are not showing the cardiotoxicity associated with anthracyclines. Sandra explains, "Anthracyclines are characteristically cardiotoxic. And we have just conducted a study of over 160 patients who have received this, and some of them for quite a long period of time. And we have not seen any cardiotoxicity. So we have one of the anthracyclines that is the first to actually cross the blood-brain barrier without any help from other mechanisms, and it also doesn't cause cardiotoxicity. So we have a really open field to be able to further develop this drug. And we know that this drug, based on all of our preclinical studies, is very effective against glioma cells." "This is to the great credit of the chemists that we've been working with. Can I develop a compound that can not be a substrate for this, so it can't even bind to this efflux transporter and can slip by? But not only that, can it be lipophilic, meaning it can get through all those membranes, and it can be something that leaks into the brain itself. So the two molecules that we have are not substrates for these multidrug-resistant transporters. They're also very highly lipophilic, meaning they're very oily. And so I guess this has two meanings to it, but they're oily and then they slip into the brain and are able to do what they're supposed to be doing, which is the inhibition of tumor growth and killing the tumor cells." #CNSPharma #Glioblastoma ##BrainCancer #BloodBrainBarrier #NeuroOncology #CancerResearch #DrugDevelopment #BrainTumor cnspharma.com Listen to the podcast here  

New indication for Kerendia; investigational therapy shows promise for hypertension; Novolog interchangeable biosimilar gets approval; trial results for hormone-free contraceptive; Shingrix now supplied in a prefilled syringe.

Today on Raise the Line, we bring you the unlikely and inspiring story of a woman who was afraid of blood as a child but became an accomplished nurse; who struggled with learning disabilities but became an effective educator; and who, despite lacking business experience or knowledge of graphics, built a successful company that produces visually rich educational materials for nurses and other providers. “I think the theme of my life has been I have struggled with learning, and I didn't want other people to struggle,” says Jennifer Zahourek, RN, the founder and CEO of RekMed which has developed a sequential, interactive learning system that includes illustrated planners, books, and videos used by millions of students and providers. The initial focus was to provide nurses with everything they needed to know from “the basics to the bedside” but RekMed now offers content for medics, respiratory therapists, medical assistants, and veterinarians as well. Driven by her belief in the power of visual learning and her “just freakin' do it” attitude, Jennifer overcame her fear of launching a business and quickly realized just how well nursing had prepared her for the hard work and unpredictability of entrepreneurship. “Nursing teaches you how to just be resilient, to pivot, to delegate, to work on a team and to handle high stress. I think nurses could literally be some of the best entrepreneurs on the planet,” she tells host Lindsey Smith. Tune in to this lively and valuable conversation as Jennifer shares lessons from bootstrapping a publishing company, insights on the evolving landscape of healthcare education, and advice on embracing change in nursing, especially with the expanding role of AI. Mentioned in this episode:RekMed If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Dr. Anne Marie Morse walks into the studio like a one-woman Jersey Broadway show and leaves behind the best damn TED Talk you've never heard. She's a neurologist, sleep medicine doc, narcolepsy expert, founder of D.A.M.M. Good Sleep, and full-time myth buster in a white coat. We talk about why sleep isn't a luxury, why your mattress does matter, and how melatonin is the new Flintstones vitamin with a marketing budget. We unpack the BS around sleep hygiene, blow up the medical gaslighting around “disorders,” and dig into how a former aspiring butterfly became one of the loudest voices for patient-centered science. Also: naps, kids, burnout, CPAPs, co-sleeping, airport pods, the DeLorean, and Carl Sagan. If you think you're getting by on five hours of sleep and vibes, you're not. This episode will make you want to take a nap—and then call your doctor.RELATED LINKSdammgoodsleep.com: https://www.dammgoodsleep.comLinkedIn: https://www.linkedin.com/in/anne-marie-morse-753b2821/Instagram: https://www.instagram.com/dammgoodsleepDocWire News Author Page: https://www.docwirenews.com/author/anne-marie-morseSleep Review Interview: https://sleepreviewmag.com/practice-management/marketing/word-of-mouth/sleep-advocacy-anne-marie-morse/Geisinger Bio: https://providers.geisinger.org/provider/anne-marie-morse/756868SWHR Profile: https://swhr.org/team/anne-marie-morse-do-faasm/FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode was recorded at the 2025 Petfood Forum in Kansas City, Missouri.  Austin begins with an overview of the Association of American Feed Control Officials (AAFCO). Their membership consists of all government officials in the US and other countries who are charged by law to regulate animal feed, including pet food, in their jurisdictions. Canada, Costa Rica, and the US all participate in AAFCO. In the US, animal feed regulation is an integrated food safety system with a partnership between state and federal regulators as well as FDA. AAFCO's ultimate goal is to harmonize animal feed regulation across all states and provide a level playing field for the industry. (8:14)He goes on to explain that AAFCO and FDA's Center for Veterinary Medicine had a long-standing MOU in place that outlined an ingredient approval pathway that ended on October 1, 2024. FDA chose not to renew that MOU to focus on improving their other regulatory pathways, the Food Additive Petition Process and the Generally Regarded as Safe (GRAS) Notice Program. The FDA also has a new Animal Food Ingredient Consultation Process for ingredient approval. AAFCO has partnered with Kansas State University's Olathe Innovation Campus to scientifically review new ingredients, then bring them back through the AAFCO process to get formal approval. Ingredient companies can choose one of these four pathways for new ingredient approval. (10:05) Dr. Starkey notes that the process a company chooses will depend on the ingredient. If it's similar to ingredients proven safe on the market already, the KSU-AAFCO system would be a good route. If it's something a little more sophisticated or a new chemical, that may be more appropriate for a food additive petition, where toxicology studies would be conducted. (12:49)The panel discusses how scrutiny of GRAS rules might impact the pet food industry. Dr. Larson explains the scientific rigor involved in evaluating new ingredients. Dr. Starkey notes that there are different levels of GRAS, one of which is self-affirmed, which might be the one under the most scrutiny at this point. The panel agrees that transparency is critical for consumer confidence and ensuring health and safety of pets. (15:47)Austin talks about some of the ripple effects of the federal reduction in force in the regulatory arena. He and Dr. Larson talk about how the AAFCO-K-State partnership came to be, how K-State is ramping up to manage this project, and future plans for the partnership. (19:52)Dr. Starkey underlines the importance of timely ingredient approvals and how the new AAFCO-K-State partnership allows for companies to be more competitive due to the speed of approvals. Austin notes that an ideal submission with no follow-up questions or back-and-forth would have taken about 18 months to get approval under the old MOU between AAFCO and FDA, and a very small percentage of applications would be considered ideal. With the new AAFCO-K-State process, an expert panel reviews the submission in 60-90 days and the entire approval process is cut roughly in half, to about nine months. (25:55)Scott and the panel discuss how approval pathways differ for ingredient approval based on the claim being made. For example, is it a nutrient or is there some sort of pharmaceutical claim? (28:36)Panelists share their take-home thoughts. (37:19)Please subscribe and share with your industry friends to invite more people to join us at the Real Science Exchange virtual pub table.  If you want one of our Real Science Exchange t-shirts, screenshot your rating, review, or subscription, and email a picture to anh.marketing@balchem.com. Include your size and mailing address, and we'll mail you a shirt.

“Very often, doctors try to suppress what they feel or don't even have the vocabulary to describe their emotions,” says Professor Alicja Galazka of the University of Silesia, an observation based on decades of work with physicians to enhance their emotional intelligence and resilience. Galazka, a psychotherapist, psychologist, lecturer and coach, believes this deficit is rooted in part in a lack of instruction in the internal and external psychological dimensions of being a medical provider. “There is not enough space created in medical school for teaching and training students about how to deal with their own stress and all of the skills connected to building relationships with patients,” she tells host Michael Carrese. Those same skills are also critical to working effectively as a member of a care team, which is an increasingly common arrangement in hospitals and clinics. Galazka employs simulations, dramatic role-playing, mindfulness, Acceptance and Commitment Therapy and other methods in her work with an eye on increasing the emotional agility and sensitivity of her trainees and clients. Tune in to this thoughtful episode of Raise the Line to hear Galazka's ideas on how to reshape medical training, why she is a proponent of narrative medicine, and the merits of embedding psychologists on care teams as a resource for both patients and providers. Mentioned in this episode:University of SilesiaInternational Association of Coaching Institutes If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Andrew and Tom discuss Trump's threat of 50% tariffs on copper and 200% on pharmaceuticals, the EU trade deal is ready to be signed, and Apple is losing executives. For information on how to join the Zoom calls live each morning at 8:30 EST, visit:https://www.narwhal.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhal.com/disclosure

Gigi Robinson grew up with Ehlers-Danlos syndrome, a disease that turns your joints into overcooked spaghetti. Instead of letting it sideline her, she built a career out of telling the truth about invisible illness. We talk about what it takes to grow up faster than you should, why chronic illness is the worst unpaid internship, and how she turned her story into a business. You'll hear about her days schlepping to physical therapy before sunrise, documenting the sterile absurdity of waiting rooms, and finding purpose in the mess. Gigi's not interested in pity or polished narratives. She wants you to see what resilience really looks like, even when it's ugly. If you think you know what an influencer does, think again. This conversation will challenge your assumptions about work, health, and what it means to be seen.RELATED LINKSGigi Robinson Website: https://www.gigirobinson.comLinkedIn: https://www.linkedin.com/in/gigirobinsonInstagram: https://www.instagram.com/itsgigirobinsonTikTok: @itsgigirobinsonA Kids Book About Chronic Illness: https://akidsco.com/products/a-kids-book-about-chronic-illnessFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Go to https://cozyearth.com and use code HUMANHR for 40% off their best-selling sheets, pajamas, towels, and more. And if you get a post-purchase survey? Let them know you heard about Cozy Earth right here.In this episode, Traci Chernoff interviews Steven Swan, CEO of the Swan Group Executive Search Firm, discussing the evolving landscape of recruiting, particularly the influence of AI. They explore the balance between speed and quality in recruitment, the importance of human connection, and the advantages of external recruiting. Steven shares insights on crafting effective resumes and the purpose behind his podcast, emphasizing the need for emotional intelligence in decision-making during job changes.Chapters00:00 Introduction to Steve Swan and His Journey03:04 The Impact of AI on Recruiting06:02 Quality vs. Speed in Recruitment09:06 The Role of Human Connection in Recruitment12:00 The Advantages of External Recruiting15:11 Crafting Effective Resumes and LinkedIn Profiles17:56 The Purpose Behind the Podcast20:58 Advice for Aspiring Recruiters23:59 Navigating Job Changes and Emotional IntelligenceWe hope you enjoyed this episode with Steven Swan. If you found our discussion insightful, we'd like you to take a moment to rate our podcast. Your feedback helps us grow and reach more listeners who are passionate about these topics. You can also leave a review and tell us what you loved or what you'd like to hear more of - we're all ears!Don't forget to rate, review, and subscribe! Plus, leave a comment if you're catching this episode on Spotify or YouTube.About Our Guest: Steve Swan stands at the helm of The Swan Group Executive Search Firm as its CEO and Principal, carving a niche in the Pharma/Biotech industries with a keen focus on IT. His fervor for industry insights and a knack for bridging the gap between top professionals and industry demands have been instrumental in elevating organizations and propelling careers forward.Steve helms the popular podcast “Biotech Bytes.” A show that offers a stage for dialogue with IT luminaries in Biotechnology and Pharmaceuticals. Each episode delves into the minds of industry trailblazers, unpacking best practices and strategies that shape the life sciences realm. Steve's academic background in Psychology has helped him to understand both parties' deeper needs and motivations which is paramount to delivering candidates who become long-term  assets to the company. At the core of The Swan Group's philosophy is the ability to discern and fulfill what success means for both candidates and clients. Outside of work, Steve, once an avid mountain bike racer, has reignited his passion for cycling and aspires to traverse the U.S. on  two wheels. He lives in New Jersey with his wife and two daughters.Connect with Steven Swan here:LinkedIn: https://www.linkedin.com/in/swangroup/ Website: https://swangroup.net/ Connect with Traci here: ⁠https://linktr.ee/HRTraci⁠Disclaimer: Thoughts, opinions, and statements made on this podcast are not a reflection of the thoughts, opinions, and statements of the Company by whom Traci Chernoff is actively employed.Please note that this episode may contain paid endorsements and advertisements for products or services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.

Thanks to our Partners, NAPA Auto Care and NAPA TRACS Recorded at the TST Big Event, John Anello passionately advocates for holistic health and nutrition, drawing from personal experiences and research. He shares practical tips on balanced eating, the power of natural, unprocessed foods like homemade beet juice, and the benefits of exercise and lifestyle choices for longevity and disease prevention. The conversation sheds light on common health challenges in the automotive industry and encourages listeners to take charge of their well-being through regular health monitoring, proactive self-care, and informed dietary decisions. Show Notes Watch Full Video Episode TST Big Event 2025: https://www.tstseminars.org/ Introduction (00:00:00) John's Background and Early Health Observations (00:01:56) COVID-19 as a Catalyst for Health Focus (00:05:56) Observations in Automotive Shops (00:07:43) Proactive Health Diagnostics (00:09:25) Body Aging, Stress, and Diet Fundamentals (00:13:34) Moderation and Understanding Nutrition (00:15:01) Cholesterol, Brain Health, and Immune Chicken Recipe (00:16:26) Supplements, Sunlight, and Exercise (00:24:12) Medication, Longevity, and Statins (00:26:26) Meal Prep, Containers, and Italian Diet (00:29:01) Sugar, Diabetes, and Electric Food (00:30:47) Discipline, Regimen, and Sleep (00:35:51) Organic Food, Farming Practices, and Minerals (00:38:01) Detoxing, Chemical Exposure, and Testing (00:41:01) Doctors, Pharmaceuticals, and Personal Choice (00:42:58) Dental Health and Natural Remedies (00:43:52) Thanks to our Partners, NAPA Auto Care and NAPA TRACS Learn more about NAPA Auto Care and the benefits of being part of the NAPA family by visiting https://www.napaonline.com/en/auto-care NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Connect with the Podcast: Follow on Facebook: https://www.facebook.com/RemarkableResultsRadioPodcast/ Join Our Virtual Toastmasters Club: https://remarkableresults.biz/toastmasters Join Our Private Facebook Community: https://www.facebook.com/groups/1734687266778976 Subscribe on YouTube: https://www.youtube.com/carmcapriotto Follow on LinkedIn: https://www.linkedin.com/in/carmcapriotto/ Follow on Instagram:

Professors Daniel Carpenter and Timo Minssen explore evolving pharma and medical device regulation, including the role of clinical trials, while Microsoft applied scientist Chad Atalla shares where AI governance stakeholders might find inspiration in the fields.Show notes: https://www.microsoft.com/en-us/research/podcast/ai-testing-and-evaluation-learnings-from-pharmaceuticals-and-medical-devices/

In this Huberman Lab Essentials episode, I explore major depression, including its underlying biology and discuss science-based approaches to alleviate symptoms and improve mood. I describe the wide-ranging symptoms of depression and explain how key neurotransmitters, hormones, stress, genetics and inflammation contribute to its development and persistence. I also cover treatment options, from traditional classes of antidepressant medications to emerging therapies such as ketamine and psilocybin. Finally, I highlight lifestyle-based tools, including exercise, supplementation and dietary strategies that can help manage depressive symptoms and promote mental well-being. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman BetterHelp: https://betterhelp.com/huberman Our Place: https://fromourplace.com/huberman Timestamps 00:00:00 Major Depression 00:01:10 Depression Symptoms 00:06:14 Sponsor: BetterHelp 00:07:33 Pharmaceuticals for Depression, SSRIs; Norepinephrine, Dopamine & Serotonin 00:14:33 Thyroid Hormone, Cortisol, Stress & Depression, Menstrual Cycle, Genetics 00:17:43 Sponsor: AG1 00:19:20 Increase Norepinephrine, Tools: Deliberate Cold Exposure & Exercise 00:21:40 Chronic Inflammation & Depression, Tools: Omega-3s (EPA) & Exercise 00:26:49 Sponsor: Our Place 00:28:41 Tool: Creatine Monohydrate Supplementation & Improving Depression 00:30:20 Novel Depression Therapies, Ketamine, Psilocybin 00:35:29 Ketogenic Diet & Refractory Depression, GABA 00:37:57 Recap & Key Takeaways Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices